238 related articles for article (PubMed ID: 35417793)
21. Effects of repeated transcranial magnetic stimulation in the dorsolateral prefrontal cortex versus motor cortex in patients with neuropathic pain after spinal cord injury: a study protocol.
Huang M; Luo X; Zhang C; Xie YJ; Wang L; Wan T; Chen R; Xu F; Wang JX
BMJ Open; 2022 Mar; 12(3):e053476. PubMed ID: 35277402
[TBL] [Abstract][Full Text] [Related]
22. Observations of Autonomic Variability Following Central Neuromodulation for Chronic Neuropathic Pain in Spinal Cord Injury.
Karri J; Li S; Chen YT; Stampas A; Li S
Neuromodulation; 2021 Apr; 24(3):427-433. PubMed ID: 31199549
[TBL] [Abstract][Full Text] [Related]
23. The Impact of Activity-Based Interventions on Neuropathic Pain in Experimental Spinal Cord Injury.
Chen J; Weidner N; Puttagunta R
Cells; 2022 Sep; 11(19):. PubMed ID: 36231048
[TBL] [Abstract][Full Text] [Related]
24. Exercise training modulates glutamic acid decarboxylase-65/67 expression through TrkB signaling to ameliorate neuropathic pain in rats with spinal cord injury.
Li X; Wang Q; Ding J; Wang S; Dong C; Wu Q
Mol Pain; 2020; 16():1744806920924511. PubMed ID: 32418502
[TBL] [Abstract][Full Text] [Related]
25. Neuromodulation for Medically Refractory Neuropathic Pain: Spinal Cord Stimulation, Deep Brain Stimulation, Motor Cortex Stimulation, and Posterior Insula Stimulation.
Galafassi GZ; Simm Pires de Aguiar PH; Simm RF; Franceschini PR; Filho MP; Pagura JR; Pires de Aguiar PH
World Neurosurg; 2021 Feb; 146():246-260. PubMed ID: 33217591
[TBL] [Abstract][Full Text] [Related]
26. Longstanding neuropathic pain after spinal cord injury is refractory to transcranial direct current stimulation: a randomized controlled trial.
Wrigley PJ; Gustin SM; McIndoe LN; Chakiath RJ; Henderson LA; Siddall PJ
Pain; 2013 Oct; 154(10):2178-2184. PubMed ID: 23831866
[TBL] [Abstract][Full Text] [Related]
27. Is transcranial magnetic stimulation as treatment for neuropathic pain in patients with spinal cord injury efficient? A systematic review.
Saleh C; Ilia TS; Jaszczuk P; Hund-Georgiadis M; Walter A
Neurol Sci; 2022 May; 43(5):3007-3018. PubMed ID: 35239053
[TBL] [Abstract][Full Text] [Related]
28. Acupuncture for neuropathic pain in adults.
Ju ZY; Wang K; Cui HS; Yao Y; Liu SM; Zhou J; Chen TY; Xia J
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD012057. PubMed ID: 29197180
[TBL] [Abstract][Full Text] [Related]
29. On the therapeutic targets and pharmacological treatments for pain relief following spinal cord injury: A mechanistic review.
Fakhri S; Abbaszadeh F; Jorjani M
Biomed Pharmacother; 2021 Jul; 139():111563. PubMed ID: 33873146
[TBL] [Abstract][Full Text] [Related]
30. Disentangling the Effects of Spinal Cord Injury and Related Neuropathic Pain on Supraspinal Neuroplasticity: A Systematic Review on Neuroimaging.
Huynh V; Rosner J; Curt A; Kollias S; Hubli M; Michels L
Front Neurol; 2019; 10():1413. PubMed ID: 32116986
[No Abstract] [Full Text] [Related]
31. Cervical spinal cord injury-induced neuropathic pain in male mice is associated with a persistent pro-inflammatory macrophage/microglial response in the superficial dorsal horn.
Brown EV; Falnikar A; Heinsinger N; Cheng L; Andrews CE; DeMarco M; Lepore AC
Exp Neurol; 2021 Sep; 343():113757. PubMed ID: 33991526
[TBL] [Abstract][Full Text] [Related]
32. Electroencephalographic Predictors of Neuropathic Pain in Subacute Spinal Cord Injury.
Vuckovic A; Jajrees M; Purcell M; Berry H; Fraser M
J Pain; 2018 Nov; 19(11):1256.e1-1256.e17. PubMed ID: 29751110
[TBL] [Abstract][Full Text] [Related]
33. Indicators of central sensitization in chronic neuropathic pain after spinal cord injury.
Lütolf R; Rosner J; Curt A; Hubli M
Eur J Pain; 2022 Nov; 26(10):2162-2175. PubMed ID: 36008094
[TBL] [Abstract][Full Text] [Related]
34. Interventions for treating neuropathic pain in people with sickle cell disease.
Asnani MR; Francis DK; Brandow AM; Hammond Gabbadon CE; Ali A
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012943. PubMed ID: 31273755
[TBL] [Abstract][Full Text] [Related]
35. Administration of ONO-2506 suppresses neuropathic pain after spinal cord injury by inhibition of astrocytic activation.
Ishiguro H; Kaito T; Hashimoto K; Kushioka J; Okada R; Tsukazaki H; Kodama J; Bal Z; Ukon Y; Takenaka S; Makino T; Sakai Y; Yoshikawa H
Spine J; 2019 Aug; 19(8):1434-1442. PubMed ID: 30974239
[TBL] [Abstract][Full Text] [Related]
36. A clinical review of the use of Botulinum Toxin type A in managing central neuropathic pain in patients with spinal cord injury.
Lakra C; Cohen H
J Spinal Cord Med; 2022 Sep; 45(5):651-655. PubMed ID: 33263489
[TBL] [Abstract][Full Text] [Related]
37. Central Neuropathic Mechanisms in Pain Signaling Pathways: Current Evidence and Recommendations.
Viswanath O; Urits I; Burns J; Charipova K; Gress K; McNally A; Urman RD; Welschmeyer A; Berger AA; Kassem H; Sanchez MG; Kaye AD; Eubanks TN; Cornett EM; Ngo AL
Adv Ther; 2020 May; 37(5):1946-1959. PubMed ID: 32291648
[TBL] [Abstract][Full Text] [Related]
38. Targeted therapies using electrical and magnetic neural stimulation for the treatment of chronic pain in spinal cord injury.
Moreno-Duarte I; Morse LR; Alam M; Bikson M; Zafonte R; Fregni F
Neuroimage; 2014 Jan; 85 Pt 3():1003-13. PubMed ID: 23727533
[TBL] [Abstract][Full Text] [Related]
39. Noninvasive Brain Stimulation Does Not Improve Neuropathic Pain in Individuals With Spinal Cord Injury: Evidence From a Meta-Analysis of 11 Randomized Controlled Trials.
Yu B; Qiu H; Li J; Zhong C; Li J
Am J Phys Med Rehabil; 2020 Sep; 99(9):811-820. PubMed ID: 32175926
[TBL] [Abstract][Full Text] [Related]
40. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
